Terms: = Bone cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Treatment
23 results:
1. New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils.
Theyab A; Algahtani M; Alsharif KF; Hawsawi YM; Alghamdi A; Alghamdi A; Akinwale J
Hematology; 2021 Dec; 26(1):628-636. PubMed ID: 34494505
[TBL] [Abstract] [Full Text] [Related]
2. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Dannenmann B; Klimiankou M; Oswald B; Solovyeva A; Mardan J; Nasri M; Ritter M; Zahabi A; Arreba-Tutusaus P; Mir P; Stein F; Kandabarau S; Lachmann N; Moritz T; Morishima T; Konantz M; Lengerke C; Ripperger T; Steinemann D; Erlacher M; Niemeyer CM; Zeidler C; Welte K; Skokowa J
Cell Stem Cell; 2021 May; 28(5):906-922.e6. PubMed ID: 33894142
[TBL] [Abstract] [Full Text] [Related]
3. Effect of the unfolded protein response and oxidative stress on mutagenesis in csf3r: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.
Sapra A; Jaksik R; Mehta H; Biesiadny S; Kimmel M; Corey SJ
Mutagenesis; 2020 Dec; 35(5):381-389. PubMed ID: 33511998
[TBL] [Abstract] [Full Text] [Related]
4. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract] [Full Text] [Related]
5. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
Yılmaz Karapınar D; Patıroğlu T; Metin A; Çalışkan Ü; Celkan T; Yılmaz B; Karakaş Z; Karapınar TH; Akıncı B; Özkınay F; Onay H; Yeşilipek MA; Akar HH; Tüysüz G; Tokgöz H; Özdemir GN; Aslan Kıykım A; Karaman S; Kılınç Y; Oymak Y; Küpesiz A; Olcay L; Keskin Yıldırım Z; Aydoğan G; Gökçe M; İleri T; Aral YZ; Bay A; Atabay B; Kaya Z; Söker M; Özdemir Karadaş N; Özbek U; Özsait Selçuk B; Özdemir HH; Uygun V; Tezcan Karasu G; Yılmaz Ş
Pediatr Blood Cancer; 2019 Oct; 66(10):e27923. PubMed ID: 31321910
[TBL] [Abstract] [Full Text] [Related]
6. Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.
Wojdyla T; Mehta H; Glaubach T; Bertolusso R; Iwanaszko M; Braun R; Corey SJ; Kimmel M
PLoS Comput Biol; 2019 Jan; 15(1):e1006664. PubMed ID: 30615612
[TBL] [Abstract] [Full Text] [Related]
7. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.
Patel KP; Ruiz-Cordero R; Chen W; Routbort MJ; Floyd K; Rodriguez S; Galbincea J; Barkoh BA; Hatfield D; Khogeer H; Kanagal-Shamanna R; Yin CC; Zuo Z; Loghavi S; Ok CY; DiNardo CD; Luthra R; Medeiros LJ
J Mol Diagn; 2019 Jan; 21(1):89-98. PubMed ID: 30577887
[TBL] [Abstract] [Full Text] [Related]
8. [Preliminary report on prospective, multicenter, open research of selective surgery after expandable stent combined with neoadjuvant chemotherapy in the treatment of obstructive left hemicolon cancer].
Han J; Wang Z; Dai Y; Li X; Qian Q; Wang G; Wei G; Zeng W; Ma L; Zhao B; Wang Y; Yang K; Ding Z; Hu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1233-1239. PubMed ID: 30506533
[TBL] [Abstract] [Full Text] [Related]
9. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with csf3r mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
10. Game of clones: the genomic evolution of severe congenital neutropenia.
Touw IP
Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
[TBL] [Abstract] [Full Text] [Related]
11. Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization.
Castelli R; Cugno M; Gianelli U; Pancrazzi A; Vannucchi AM
Pathol Res Pract; 2015 Apr; 211(4):341-3. PubMed ID: 25480691
[TBL] [Abstract] [Full Text] [Related]
12. The csf3r T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW
Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659
[TBL] [Abstract] [Full Text] [Related]
13. Hematopoietic stem cell transplantation in severe congenital neutropenia.
Carlsson G; Winiarski J; Ljungman P; Ringdén O; Mattsson J; Nordenskjöld M; Touw I; Henter JI; Palmblad J; Fadeel B; Hägglund H
Pediatr Blood Cancer; 2011 Mar; 56(3):444-51. PubMed ID: 21072829
[TBL] [Abstract] [Full Text] [Related]
14. Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents.
Shaked Y; Tang T; Woloszynek J; Daenen LG; Man S; Xu P; Cai SR; Arbeit JM; Voest EE; Chaplin DJ; Smythe J; Harris A; Nathan P; Judson I; Rustin G; Bertolini F; Link DC; Kerbel RS
Cancer Res; 2009 Oct; 69(19):7524-8. PubMed ID: 19738066
[TBL] [Abstract] [Full Text] [Related]
15. [Gefitinib in the treatment of refractory non-small cell lung cancer].
Xu JF; Zhou CC; Li AW
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):938-40. PubMed ID: 18478936
[TBL] [Abstract] [Full Text] [Related]
16. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
[TBL] [Abstract] [Full Text] [Related]
17. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
[TBL] [Abstract] [Full Text] [Related]
18. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.
Hunter MG; Jacob A; O'donnell LC; Agler A; Druhan LJ; Coggeshall KM; Avalos BR
J Immunol; 2004 Oct; 173(8):5036-45. PubMed ID: 15470047
[TBL] [Abstract] [Full Text] [Related]
19. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials.
Sze WM; Shelley M; Held I; Mason M
Cochrane Database Syst Rev; 2004; 2002(2):CD004721. PubMed ID: 15106258
[TBL] [Abstract] [Full Text] [Related]
20. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
Hunter MG; Druhan LJ; Massullo PR; Avalos BR
Am J Hematol; 2003 Nov; 74(3):149-55. PubMed ID: 14587040
[TBL] [Abstract] [Full Text] [Related]
[Next]